AI-driven drug discovery company Insilico Medicine raised approximately HKD 2.28 billion (more than US$290 million) in its initial public offering on the Hong Kong Stock …
Read More
In what feels like the moment biotech meets everyday life, the U.S. Food and Drug Administration has just approved the first daily oral weight-loss pill …
Read More
AI drug developer Insilico Medicine has returned to the Hong Kong public markets with an updated IPO prospectus, targeting about $292 million in proceeds. The submission …
Read More
Bioptimus has announced M-Optimus, a foundation model trained on multimodal biomedical data including histology, bulk and spatial transcriptomics, and clinical records, aiming to simulate biological …
Read More
Biotechnology has revolutionized the healthcare industry, and with the increasing demand for advanced therapies, the focus has shifted towards innovative therapeutic modalities. In this blog …
Read More
Latent Labs, which emerged from stealth earlier this year with $50 million in funding, has announced Latent-X2, a generative AI model that produces antibody and …
Read More
